Assess neonatal jaundice risk using Bhutani nomogram zones, AAP 2022 phototherapy thresholds, rate of bilirubin rise, and exchange transfusion thresholds adjusted for gestational age and risk factors.
Neonatal hyperbilirubinemia is the most common condition requiring medical attention in newborns, affecting approximately 60% of term and 80% of preterm infants in the first week of life. While physiologic jaundice is generally benign, severe unconjugated hyperbilirubinemia can cause bilirubin-induced neurological dysfunction (BIND) and, in rare cases, kernicterus — a devastating form of permanent brain damage.
This calculator implements the Bhutani hour-specific bilirubin nomogram to classify infants into risk zones (low, low-intermediate, high-intermediate, and high) based on their total serum bilirubin (TSB) and postnatal age in hours. It computes gestational age- and risk factor-adjusted phototherapy and exchange transfusion thresholds based on the updated AAP 2022 clinical practice guideline, calculates the rate of bilirubin rise (critical for identifying hemolytic disease), and evaluates direct bilirubin ratios to flag conjugated hyperbilirubinemia which requires a different workup.
Early identification of high-risk neonates using hour-specific percentile tracking, combined with awareness of neurotoxicity risk factors such as isoimmune hemolytic disease, G6PD deficiency, prematurity, and hypoalbuminemia, is the cornerstone of preventing severe hyperbilirubinemia and its irreversible neurological complications.
This calculator provides comprehensive neonatal jaundice risk assessment using the Bhutani nomogram, AAP 2022-aligned phototherapy and exchange thresholds adjusted for gestational age and neurotoxicity risk factors, bilirubin rate of rise calculation, and conjugated hyperbilirubinemia screening — all essential components for safe newborn jaundice management. Keep these notes focused on your operational context. Tie the context to the calculator’s intended domain.
Bhutani zone: hour-specific TSB percentile classification. Phototherapy threshold ≈ 18 mg/dL (≥38 wks, low risk), adjusted downward for prematurity and risk factors. Exchange threshold ≈ 25 mg/dL with similar adjustments. Rate of rise = TSB / (age in hours / 24); rapid rise >0.2 mg/dL/hr suggests hemolysis.
Result: High-Intermediate zone (75th–95th percentile), Phototherapy threshold 18 mg/dL, Below phototherapy threshold
A TSB of 14 mg/dL at 48 hours in a healthy term infant falls in the high-intermediate Bhutani zone. While below the phototherapy threshold of 18 mg/dL, this infant needs close follow-up with repeat TSB in 12–24 hours.
Use consistent units, verify assumptions, and document conversion standards for repeatable outcomes.
Most mistakes come from mixed standards, rounding too early, or misread labels. Recheck final values before use. ## Practical Notes
Use this for repeatability, keep assumptions explicit. ## Practical Notes
Track units and conversion paths before applying the result. ## Practical Notes
Use this note as a quick practical validation checkpoint. ## Practical Notes
Keep this guidance aligned to expected inputs. ## Practical Notes
Use as a sanity check against edge-case outputs. ## Practical Notes
Capture likely mistakes before publishing this value. ## Practical Notes
Document expected ranges when sharing results.
Per AAP 2022: when TSB reaches the hour-specific phototherapy threshold adjusted for gestational age and neurotoxicity risk factors. For a healthy ≥38-week infant, this is approximately 18 mg/dL at 72 hours.
The Bhutani nomogram is a chart that plots total serum bilirubin against postnatal age in hours, classifying infants into low-risk, low-intermediate, high-intermediate, and high-risk zones to predict the likelihood of subsequent severe hyperbilirubinemia. Use this as a practical reminder before finalizing the result.
Breastfeeding jaundice (early, days 2–5) occurs due to inadequate milk intake causing dehydration and reduced bilirubin elimination. Breast milk jaundice (late, weeks 1–12) involves substances in breast milk that inhibit hepatic bilirubin conjugation. Both are manageable with feeding support.
TSB ≥25 mg/dL in a term infant approaches the exchange transfusion threshold and carries significant risk for neurological damage. Any infant in the high-risk Bhutani zone needs urgent evaluation.
Rate of bilirubin rise >0.2 mg/dL/hr (or >5 mg/dL/day) suggests hemolytic disease (ABO/Rh incompatibility, G6PD deficiency) and portends rapid progression to dangerous levels requiring intensive phototherapy or exchange.
Direct (conjugated) bilirubin should be checked if jaundice persists beyond 2 weeks, if direct bilirubin is >1.0 mg/dL or >20% of total, or if the infant appears ill. Elevated direct bilirubin suggests biliary atresia, hepatitis, or metabolic disease.